We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Study of Dasatinib in Patients With Imatinib Resistant or Intolerant Chronic Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00866736
Recruitment Status : Completed
First Posted : March 20, 2009
Last Update Posted : September 15, 2015
Epidemiological and Clinical Research Information Network
Information provided by:
Kanto CML Study Group